[Pulmonary mycoses; laboratory diagnosis, antimycotic therapy].
The microscopic, cultural and serological techniques for the diagnosis of European and non-European systemic mycoses involving the respiratory tract are reviewed. The antimicrobial, therapeutic and toxic properties of those antimycotic drugs are discussed, which can be used in the treatment of pulmonary mycoses. Data on biotransformation, kinetics and dosage are reported.
D000287:Administration, Topical; D000666:Amphotericin B / Q000627:therapeutic use; D019411:Clinical Laboratory Techniques; D003022:Clotrimazole / Q000627:therapeutic use; D004352:Drug Resistance, Microbial; D004359:Drug Therapy, Combination; D005437:Flucytosine / Q000627:therapeutic use; D006801:Humans; D007093:Imidazoles / Q000627:therapeutic use; D008172:Lung Diseases, Fungal / Q000188:drug therapy; D008825:Miconazole / Q000627:therapeutic use; D010866:Natamycin / Q000627:therapeutic use; D009761:Nystatin / Q000627:therapeutic use; D013183:Sputum / Q000382:microbiology; D015003:Yeasts / Q000302:isolation & purification
D007093:Imidazoles; D009761:Nystatin; D008825:Miconazole; D000666:Amphotericin B; D010866:Natamycin; D005437:Flucytosine; D003022:Clotrimazole
Lungen-Mykosen Laboratoriumsdiagnose, antimykotische Therapie